Compounding pharmacies that have been selling hundreds of thousands of doses of copies of Lilly's Zepbound and Novo's Wegovy while the medicines were in shortage are running out of time to produce ...
We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Eli Lilly (LLY) announced the launch of 7.5 mg and 10 mg Zepbound single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program. Lilly also reduced the price of the 2.5 mg ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...
U.S. pharmaceutical giant Eli Lilly (LLY) is lowering the cost of its blockbuster weight loss medication Zepbound in an effort to reach more consumers. See what stocks are receiving Strong Buy ...
ByYessar Rosendar, Forbes Staff. I write about Asia's richest, fast-growing businesses, and startups. Indorama Ventures—controlled by Thailand billionaire Aloke Lohia—has agreed to buy a 24.9% ...
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Eli Lilly and Co. (LLY) and S&P Global Inc. (SPGI), as well as a micro-cap stock CVD ...
Seed and first-round funding came from 5AM Ventures, Binney Street Capital, Lilly Asia Ventures, Illumina Ventures, Bristol Myers Squibb, Osage University Partners, and Qatar Investment Authority.
and LifeSci Venture Partners, along with existing backers Lilly Asia Ventures (LAV) and LYFE Capital. Finally, Firefly Bio emerged from stealth mode with a $94 million Series A financing – co ...
At the world premiere of Netflix’s The Electric State, held in Los Angeles’ The Egyptian Theatre Hollywood, filmmaking sibling duo Joe and Anthony Russo previewed to Deadline the forthcoming ...
Eli Lilly and Company (NYSE: LLY) today announced at a press conference in Washington, D.C., plans to bolster its domestic medicine production across therapeutic areas by building four new ...
Get global perspectives and insights from CEOs on the biggest stories in business. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results